Thus, we have previously considered an in vivo strategy by which endogenous DCs are attracted to the tumor sites using a live tumor cell to express a DC chemokine, the macrophage inflammatory protein-3α (MIP-3α or CCL20), which proved to be effective in several murine tumor models.29 This evidence concerns the gene CCL20 and neoplasm.